Endocrine Abstracts

Background: We aim to test whether plasma copeptin (copeptin), the C-terminal fragment of vasopressin, has predictive value of cardiovascular events in patients with type 2 diabetes without previous cardiovascular disease who were treated in primary care.Methods: We measured copeptin in 697 patients who participated in the epidemiological study CARDIPP (Cardiovascular Risk Factors in Patients with Diabetes – a Prospective Study in Primary Care; Clin...

Background: Earlier identification of diabetes patients at high risk of developing cardiovascular complication will help develop new therapeutic targets for the prevention of secondary diseases and death.Objectives: We aim to test the predictive value of toe brachial index (TBI) as a risk marker of major adverse cardiovascular events (MACE) in patients with type 2 diabetes.Methods: TBI was measured in 741 patients with type 2 diabe...